Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

5.680
+0.52010.08%
Volume:1.36M
Turnover:7.62M
Market Cap:4.44B
PE:-30.14
High:5.770
Open:5.410
Low:5.380
Close:5.160
52wk High:11.800
52wk Low:3.980
Shares:782.00M
HK Float Shares:782.00M
Volume Ratio:6.46
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.188
ROE:-17.24%
ROA:-7.80%
PB:4.95
PE(LYR):-30.14
PS:71.21

Loading ...

JACOBIO books RMB600.62 million interim profit on 15-fold revenue surge; appoints new vice chair

Bulletin Express
·
Yesterday

Jacobio Pharmaceuticals Appoints Xiaojie Wang as Vice Chairperson

Reuters
·
Yesterday

China's Asymchem H1 Revenue Rises on Strength in Emerging Businesses

Reuters
·
Yesterday

China's Jacobio Pharmaceuticals H1 Revenue Jumps on Licensing Boost

Reuters
·
Yesterday

JACOBIO-B swings to profit with RMB 601 million interim gain

Stock News
·
Yesterday

Jacobio Pharmaceuticals Group H1 Net Income Attributable RMB 600.6 Million

THOMSON REUTERS
·
Yesterday

Jacobio Pharma Appoints Vice Chairperson, Reshuffles Senior Management

Reuters
·
Yesterday

Jacobio Pharmaceuticals - Xiaojie Wang Has Been Appointed as the Vice Chairperson

THOMSON REUTERS
·
Yesterday

Jacobio Pharmaceuticals - Yunyan Hu Tendered Resignation as Executive Vice President of Group

THOMSON REUTERS
·
Yesterday

Jacobio Pharmaceuticals Schedules 24 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express
·
Aug 12

Asian Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 12

Hong Kong stocks end lower on Wednesday; oil stocks rally on geopolitical tensions, while gold and space sectors decline

Stock News
·
Aug 11

Jacobio Pharma Projects First‐Ever Profit, Expects ≥RMB600.00 million Net Income for 1H 2026 on Licensing Windfall

Bulletin Express
·
Aug 10

Biotech Firm JACOBIO-B Anticipates First-Ever Profit of at Least RMB 600 Million

Stock News
·
Aug 10

Jacobio Pharmaceuticals Sees Significant Growth in Hy Revenue

THOMSON REUTERS
·
Aug 10

Jacobio Pharmaceuticals - Expects Net Profit of not Less than Rmb600 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 10

Jacobio Pharmaceuticals Forecasts H1 Net Profit at Least RMB 600 Million

Reuters
·
Aug 10

Jacobio Doses First Patient in Phase Iia China Trial of Jab-8263 for Rheumatoid Arthritis

Reuters
·
Jul 27

Jacobio Pharmaceuticals executes HKD 0.50 million on-market buyback, lifting treasury stock to 9.58 million shares

Bulletin Express
·
Jul 24

Jacobio Pharmaceuticals executes HK$0.50 million share buyback, lifts treasury stock to 9.48 million shares

Bulletin Express
·
Jul 23